Innate Pharma SA

IPHA·NASDAQ·$1.72Share Price as of 11/2·$162MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)04/01/26 20-FAnnual report (foreign)04/30/25 20-FAnnual report (foreign)04/04/24 20-F/AAnnual report (foreign, amended)04/20/23 20-FAnnual report (foreign)04/06/23

Disclosures

6-KForeign issuer report10/27/26 6-KForeign issuer report10/21/26 6-KForeign issuer report10/20/26 6-KForeign issuer report09/17/26 6-KForeign issuer report09/17/26

Prospectuses and Registrations

S-8Registration of securities for employees09/11/24 424B5Prospectus supplement02/06/24 F-3Shelf registration (foreign)12/20/23 424B5Prospectus supplement04/26/23 424B5Prospectus supplement05/03/22

Proxies

No matching filings.

Ownership

SC 13D/ABeneficial ownership (amended)05/07/25 SC 13D/ABeneficial ownership (amended)12/06/22 SC 13D/ABeneficial ownership (amended)10/21/22 SC 13DBeneficial ownership02/12/21 SC 13GBeneficial ownership10/23/19

Other

EFFECTRequest for effectiveness01/16/24 CORRESPCorrespondence with the SEC01/11/24 UPLOADLetter from the SEC12/26/23 EFFECTRequest for effectiveness01/28/21 CORRESPCorrespondence with the SEC01/27/21